Ask most people what causes Duchenne muscular dystrophy, and they’ll tell you the textbook answer: a genetic mutation leads to the absence of dystrophin, a protein that normally protects muscle fibres from the mechanical stress of contraction. Without it, muscle fibres are damaged with every movement, and over time that damage accumulates faster than muscle can repair itself, leading to progressive muscle loss.
That’s true, but it’s only half the story. Most of us in the field were trained to think about muscle disease primarily through the lens of damage. Increasingly, however, researchers are recognizing that it’s not only the amount of damage that matters, but also the muscle’s ability to repair itself. That second half of the story extends well beyond Duchenne and is reshaping how researchers think about muscle disease.
The repair equation
Skeletal muscle is one of the few tissues in the body with a dedicated population of adult stem cells built specifically for repair. These muscle stem cells (also known as satellite cells) sit quietly alongside muscle fibres until injury occurs. They then activate, divide, and begin the process of rebuilding damaged tissue. What happens next largely determines how well the muscle recovers.
Not every stem cell division contributes to repair in the same way. Some divisions simply replenish the stem cell pool, preserving the muscle’s regenerative capacity for the future. Others are asymmetric, producing one daughter cell that remains a stem cell and another that goes on to become new muscle tissue. These asymmetric divisions strike the balance between repairing today’s damage and preserving the ability to repair tomorrow’s.
Under healthy conditions, this system runs largely in the background. We don’t notice it because it works.
Where the system breaks down
In Duchenne, the loss of dystrophin does more than leave muscle fibres exposed to damage. Emerging evidence suggests dystrophin plays an important role in the molecular machinery that allows a dividing muscle stem cell to “read” its environment and orient itself correctly before it divides. When that cue is missing, fewer stem cells complete the asymmetric division that produces new muscle while preserving the stem cell reserve. The result is a compounding problem: muscle fibres are damaged more frequently, while the stem cells responsible for repairing them become less able to generate new muscle efficiently.
Importantly, the biology underlying these stem cell decisions isn’t unique to Duchenne. The balance between self-renewal and productive repair matters whenever ongoing muscle damage exceeds the tissue’s capacity to regenerate, regardless of the underlying cause.
Facioscapulohumeral muscular dystrophy (FSHD), for example, involves a very different genetic mechanism, one that appears to cause sporadic muscle fibre death rather than a structural vulnerability like the loss of dystrophin. Yet the consequence at the tissue level is similar: muscle damage accumulates faster than the muscle can repair it. Even ordinary, non-genetic muscle trauma depends on this same repair machinery working efficiently.
Why this reframing matters
This distinction matters because it changes the kinds of questions researchers ask, and the kinds of therapeutic strategies worth exploring. A framework built solely around “replace or protect a missing protein” points toward disease-specific, one-off solutions. A framework built around muscle regeneration points toward a therapeutic strategy with much broader potential: can that process be supported or enhanced across a range of conditions where damage and repair are out of balance, regardless of what set the imbalance in motion in the first place?
That perspective has increasingly shaped our research at Satellos. What began as a program focused on Duchenne has naturally expanded into other conditions where the common biological challenge is impaired regeneration rather than a shared genetic mutation. The cause of muscle injury may differ from disease to disease, but the regenerative machinery responding to it is remarkably consistent.
An evolving picture
None of this diminishes the importance of understanding what causes muscle damage; it broadens the picture. As tools for studying muscle stem cell behaviour continue to improve, researchers are gaining a deeper understanding of the biology of regeneration itself — not simply as the aftermath of injury, but as a therapeutic opportunity. That shift from focusing not only on preventing damage but also on restoring regeneration may ultimately reshape how we think about treating muscle disease.
